PATENT CLAIM ANALYSIS

Application Number: 15898112
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "130100"]

Abstract:
Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Claim (Index 1):
A method of treating or preventing viral infections comprising administering a therapeutically effective amount of an isolated antibody or fragment thereof to a patient in need thereof for a time sufficient to treat or prevent viral infections, wherein the antibody binds toll-like receptor 3 (TLR3) amino acid residues K416, K418, L440, N441, E442, Y465, N466, K467, Y468, R488, R489, A491, K493, N515, N516, N517, H539, N541, S571, L595, and K619 of SEQ ID NO: 2.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 88.0
- Lexical Diversity: 1.2
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15345860', '13973187', '13798494', '13230060', '12770147']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7887497887838826
- 35 USC 102 Novelty (BERT): 0.6491143005606539
- Combined Prediction Score: 0.7747862399615597
- Mean Citation Score: 603.0529359999998
- Max Citation Score: 614.1868
- Similarity Product: 599.4949760809899

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test